HCPCS Level IIdrugActive
J9269
Inj. tagraxofusp-erzs 10 mcg
BETOS: O1D
Effective: 2019-10-01
Description
Injection, tagraxofusp-erzs, 10 micrograms
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Elzonris
Manufacturer
Stemline Therapeutics, Inc.
HCPCS Dosage
10 MCG
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.